Company Sector
ADCs
ADCs, or antibody-drug conjugates, combine the targeting ability of antibodies with the payload of a cytotoxic drug. This sector page groups companies working on ADC platforms or lead ADC assets, especially in oncology where the modality has become increasingly important.
Why watch ADCs
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest ADCs news
The latest feed items from companies currently grouped under ADCs.
- 01
LEGNLegend Biotech to Host Investor Conference Call on Second Quarter 2026 Results
Source: Legend Biotech Corporation
- 02
LEGNLegend Biotech Announces CEO Transition
Source: Legend Biotech Corporation
- 03
LEGNLegend Biotech Corporation Announces Pricing of Public Offering
Source: Legend Biotech Corporation
- 04
LEGNLegend Biotech Corporation Announces Proposed Public Offering
Source: Legend Biotech Corporation
- 05
- 06
- 07
LEGNLegend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026
Source: Legend Biotech Corporation
- 08
LEGNLegend Biotech Announces Presentations at ASCO 2026
Source: Legend Biotech Corporation
- 09
STROSutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights
Source: Sutro Biopharma
- 10
LEGNLegend Biotech Reports First Quarter 2026 Results and Recent Highlights
Source: Legend Biotech Corporation
- 11
LEGNLegend Biotech Expands Scientific Advisory Expertise to Inform Future Growth
Source: Legend Biotech Corporation
- 12
LEGNLegend Biotech to Host Investor Conference Call on First Quarter 2026 Results
Source: Legend Biotech Corporation
- 13
- 14
STROSutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
Source: Sutro Biopharma
- 15
LEGNLegend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
Source: Legend Biotech Corporation
- 16
STROSutro Biopharma to Participate in Upcoming Investor Conferences
Source: Sutro Biopharma
- 17
LEGNLegend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results
Source: Legend Biotech Corporation
- 18
STROSutro Biopharma Announces Participation at the 16th World ADC London Summit
Source: Sutro Biopharma
- 19
STROSutro Biopharma Announces Pricing of $110.0 million Underwritten Offering
Source: Sutro Biopharma
- 20
LEGNLegend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use
Source: Legend Biotech Corporation
Companies in ADCs
7 companies tagged with ADCs.
Frequently Asked Questions
What does the ADCs sector include?
ADCs, or antibody-drug conjugates, combine the targeting ability of antibodies with the payload of a cytotoxic drug. This sector page groups companies working on ADC platforms or lead ADC assets, especially in oncology where the modality has become increasingly important.
How many companies are currently tagged with ADCs?
7 companies are currently grouped under ADCs on BioPharmSignal.
Which companies are most visible in the ADCs group right now?
ADCT, AMAM, IMGN, LEGN are among the companies currently shown on this sector page.
How can I watch news for ADCs?
Use the Watch button on this page to subscribe to ADCs headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for ADCs?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in ADCs.